Avatar

What Is the COVID-19 Cancer Consortium? Urgent Need to Generate Knowledge Regarding COVID-19

By Petros Grivas 7 Videos
April 18, 2020
2 Comments
Login to view comments. Click here to Login

Featured Video

16:20
Lilly

Exploring Statistically Significant Trial Data

Feat. P. A. Kaufman

Featured Video

06:28
Lilly

A Case Study of HR+, HER2- MBC With Rapid Progression

Feat. M. Dietrich

Related Content

AUTOPLAY
13:17
Platelet Disorder Support Association (PDSA)

COVID-19 Vaccine and Immune Thrombocytopenia

Feat. M. Beltrami-Moreira
21:42
UAB Hematology Review 2021

Hematologic Manifestations of COVID-19: Thrombosis Mechanisms and Risk, CO…

Feat. R. Gangaraju
25:05
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Adult Nursing Q&A Session: Autologous/Allogenic Transplant, COVID Mana…

Feat. P. Mangan, L. Perry, A. Walsh, A. Rubin, R. Golding, L. Quinn, K. Salam, K. Mcdevitt
47:07
Penn Medicine Abramson Cancer Center

Updates on Breast Care and Imaging During COVID-19: Vaccine-Related Axilla…

Feat. R. Jankowitz, E. Conant, T. D'Entremont, A. Steiner, J. Tchou
26:16
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Immunotherapy in Pediatric AML: CART33 Nursing Considerations During the P…

Feat. D. Baniewicz
17:06
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Pediatric CAR T-Cell Therapy During COVID-19: CHOP Experience

Feat. S. Maude
33:24
Zahra Pakbaz

Current Approach to Sickle Cell Anemia: COVID & SCD, Genotypes, Hemoly…

13:06
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Q&A Panel on Cell Therapy During the COVID-19 Pandemic

Feat. D. Porter, C. Bollard, G. Shah, S. Maude, S. Devine
12:10
Penn Medicine Abramson Cancer Center

2021 Updates in Medical Oncology for Lung Cancer: Targeted Therapy, Tumor …

Feat. C. Aggarwal
21:47
Total Health Conferencing

Shared Expert Experience on the CML Management in the Time of COVID-19: Ho…

Feat. T. Kadia, F. Santos, H. Malhotra
10:25
Houston Methodist DeBakey Heart and Vascular Center

COVID-19 & Cytokine Storm: What Kind of Inflammatory Markers Are Relea…

Feat. J. Chang
09:15
8th Eurasian Hematology Oncology Summit

How I Treat ET in 2021: WHO True-ET, Thromboembolic/Bleeding Complications…

Feat. D. Wolf
13:34
UAB Hematology Review 2021

CLL Management in Times of COVID-19: Frontline Acalabrutinib or Ven +/- Ob…

Feat. M. Narkhede
15:32
Penn Medicine Abramson Cancer Center

COVID-19 Vaccination Guidelines for Our Cancer Patients: What Are the Elig…

Feat. L. Schuchter
25:06
2021 Virtual KU Hematology and Medical Oncology Review

ASCO 2021 Survivorship Highlights: Remote Symptom Monitoring, Inpatient Ca…

Feat. E. Wulff-Burchfield
16:58
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Lessons Learned From irAE Management During COVID-19: Cytokine Storm, Impl…

Feat. L. Calabrese
04:06
Total Health Conferencing

Expert Experience on the CML Management in the Time of COVID-19: Preventio…

Feat. H. Malhotra
15:18
Memorial Sloan Kettering Cancer Center

MSKCC Updates on Telemedicine/Cohort Monitoring & COVID-19 Testing for…

Feat. D. Reidy-Lagunes
15:40
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases

COVID-19 & Hematologic Malignancies: What Is the Mortality Estimate Pe…

Feat. J. Leal
33:00
Total Health Conferencing

Will COVID-19 Leave Its Mark on Cancer Care?

Feat. G. Lopes